Revalesio Corporation

Revalesio Corporation

Biotechnology, 1202 E D St, Tacoma, Washington, 98421, United States, 11-50 Employees

revalesio.com

  • LinkedIn

phone no Phone Number: 25********

Who is REVALESIO CORPORATION

Revalesio is a clinical-stage pharmaceutical company committed to creating treatments for neurological diseases and conditions that lack adequate therapeutic options. Our therapies addres...

Read More

map
  • 1202 E D St, Tacoma, Washington, 98421, United States Headquarters: 1202 E D St, Tacoma, Washington, 98421, United States
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $10 Million to $25 Million

industries-icon Industry: Biotechnology

SIC SIC Code: 3561 | NAICS Code: 339999 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from REVALESIO CORPORATION

Revalesio Corporation Org Chart and Mapping

Employees

Courtney Huber

Administrative Associate

Kevin Bischof

Material Control & Logistics Specialist

Bert Van Den Bergh

Executive Chairman of the Board

Supurna Ghosh

VP of Translational Medicine

Brett Frink

Manufacturing Engineer

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Revalesio Corporation

Answer: Revalesio Corporation's headquarters are located at 1202 E D St, Tacoma, Washington, 98421, United States

Answer: Revalesio Corporation's phone number is 25********

Answer: Revalesio Corporation's official website is https://revalesio.com

Answer: Revalesio Corporation's revenue is $10 Million to $25 Million

Answer: Revalesio Corporation's SIC: 3561

Answer: Revalesio Corporation's NAICS: 339999

Answer: Revalesio Corporation has 11-50 employees

Answer: Revalesio Corporation is in Biotechnology

Answer: Revalesio Corporation contact info: Phone number: 25******** Website: https://revalesio.com

Answer: Revalesio is a clinical-stage pharmaceutical company committed to creating treatments for neurological diseases and conditions that lack adequate therapeutic options. Our therapies address cellular imbalances related to mitochondrial dysfunction and thereby modulate the immune response. They have been shown to protect neurons in models of chronic neurological diseases and improve recovery in acute neurological injury. We are partnering with internationally renowned scientists in biomedical research in a concerted effort to improve the lives of millions.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access